期刊文献+

非甾体抗炎药在降低前列腺癌发病率方面的研究进展 被引量:2

下载PDF
导出
摘要 前列腺癌是欧美国家男性最常见的恶性肿瘤之一,其发病机制及预防方案尚不明确,有研究表明非甾体抗炎药(NSAIDS)可降低前列腺癌发病率,本文就NSAIDS在降低前列腺癌发病率作用机制方面进行综述。
出处 《安徽医药》 CAS 2011年第6期768-769,共2页 Anhui Medical and Pharmaceutical Journal
  • 相关文献

参考文献24

  • 1Waddell WR,Loughry RW,et al.Sulindac for polyposis of the colon[J].J Surg Oncol,1983,24:83-7.
  • 2Roy HK,Karolski WJ,Ratashak A.Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone[J].Int J Cancer,2001,92(4):609-15.
  • 3Vane JR,Booting RM.Mechanism of action of non-steroidal anti-inflammatory drugs[J].Am J Med,1998,104(3A):2S-8S.
  • 4刘雁,李志军.非甾体抗炎药物的药理及临床应用进展[J].中国医院药学杂志,2000,20(12):748-750. 被引量:22
  • 5Uefuji K,Ichikura T,Mochizuki H.Increased expression of interleukin-1 alpha and cyclooxygenase-2 in human gastric cancer:a possible role in tumor progression[J].Anticancer Res,2005,25(5):32252.
  • 6Buttar NS,Wang KK.The "aspirin" of the new millennium:cyclooxygenase-2 inhibitors[J].Mayo Clin Proc,2000,75:1027-38.
  • 7Liu XH,Kirschenbaum A,Lu M,et al.Prostaglandin E2 stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway[J].Biochem Biophys Res Commun,2002,290(1):249-55.
  • 8Lim JT,Piazza GA,Han EK,et al.Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines[J].Biochem Pharmacol,1999,58:1097-107.
  • 9Gupta S,Srivastava M,Ahmad N,et al.Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma[J].Prostate,2000,42:73-8.
  • 10Tjandrawinata RR,Hughes-Fulford M.Up-regulation of cyclooxygenase-2 by product-prostaglandin E2[J].Adv Exp Med Biol,1997,407:163-70.

二级参考文献15

  • 1徐振宇,高建平,张征宇,葛京平,许传亮,孙颖浩.RECK基因在前列腺癌组织中的表达及其与基质金属蛋白酶的关系[J].医学研究生学报,2005,18(7):577-579. 被引量:6
  • 2徐振宇,许传亮,孙颖浩.RECK基因在前列腺组织中的表达及其与基质金属蛋白酶-9的关系[J].中华实验外科杂志,2005,22(9):1146-1146. 被引量:5
  • 3徐振宇,高建平,张征宇,葛京平,许传亮,孙颖浩.基质金属蛋白酶抑制剂RECK基因在前列腺细胞株中的表达及意义[J].中华男科学杂志,2005,11(10):727-730. 被引量:9
  • 4Sheng H,J Clin Invest,1997年,99卷,2254页
  • 5Egeblad M, Werb Z. New functions for matrix metalloproteinases in cancer progression [ J ]. Nat Rev Cancer, 2002,2 ( 3 ) : 161- 174.
  • 6Rhee JS, Coussens LM. RECKing MMP function: implications for cancer development[J]. Trends Cell Biol, 2002, 12 ( 5 ) : 209-211.
  • 7Sasahara RM, Takahashi C, Noda M. Involvement of the Sp1 site in ms-mediated downregulation of the RECK metastasis suppressor gene[J]. Biochem Biophys Res Commun, 1999, 264(3) :668- 675.
  • 8Di Sario JA, Alberts DS, Tietze CC, et al. Sulindac induces regression and prevents progression of sporadic colorectal adenomas [J]. Gastroenterology, 1997, 112(6):1284-1290.
  • 9Bissell M J, Radisky D. Putting tumors in context [ J ]. Nat Rev Cancer, 2001, 1 ( 1 ) :46-54.
  • 10Elder DJ, Hague A, Hicks DJ, et al. Differential growth inhiition by the aspirin metabolite saliclate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro transformed adenoma relative to adenoma cell lines[ J]. Cancer Res, 1996, 56(10) :2773-2776.

共引文献23

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部